Piperidinylamino-thieno[2,3-d] pyrimidine compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 18, 2006
Grant Date -
Dec 9, 2004
app pub date -
Mar 31, 2004
filing date -
Mar 31, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to 5-HT receptor antagonists. Novel piperidinylamino-thieno[2,3-d] pyrimidine compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as anxiety, depression, schizophrenia, neural injury, stroke, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully